Correlation Between Spineguard and Neovacs SA
Can any of the company-specific risk be diversified away by investing in both Spineguard and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spineguard and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spineguard and Neovacs SA, you can compare the effects of market volatilities on Spineguard and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spineguard with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spineguard and Neovacs SA.
Diversification Opportunities for Spineguard and Neovacs SA
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spineguard and Neovacs is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Spineguard and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Spineguard is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spineguard are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Spineguard i.e., Spineguard and Neovacs SA go up and down completely randomly.
Pair Corralation between Spineguard and Neovacs SA
Assuming the 90 days trading horizon Spineguard is expected to generate 0.38 times more return on investment than Neovacs SA. However, Spineguard is 2.63 times less risky than Neovacs SA. It trades about 0.12 of its potential returns per unit of risk. Neovacs SA is currently generating about 0.0 per unit of risk. If you would invest 13.00 in Spineguard on September 24, 2024 and sell it today you would earn a total of 8.00 from holding Spineguard or generate 61.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Spineguard vs. Neovacs SA
Performance |
Timeline |
Spineguard |
Neovacs SA |
Spineguard and Neovacs SA Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Spineguard and Neovacs SA
The main advantage of trading using opposite Spineguard and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spineguard position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.Spineguard vs. Kalray SA | Spineguard vs. Biosynex | Spineguard vs. Eurobio Scientific SA | Spineguard vs. OSE Pharma SA |
Neovacs SA vs. Kalray SA | Neovacs SA vs. Biosynex | Neovacs SA vs. Eurobio Scientific SA | Neovacs SA vs. OSE Pharma SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |